Health Sciences Acquisitions Corporation 2
Status: Closed Deal
U=S
| IPO Proceeds, $M | $160.00M |
|---|---|
| IPO Date | Aug 4, 2020 |
| CEO | Roderick Wong, MD |
| Left Lead | Chardan |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 + 3 + 1 + 1 + 1 |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | Orchestra BioMed, Inc. |
| Deal Announced | Jul 5, 2022 |
| Deal Size, $M | $173.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Jan 24, 2023 |
| Amendment Vote | TBD |
| Closing Date | Jan 26, 2023 |
Formerly HSAQ
OBIO
| Price | $4.02 |
|---|---|
| Last closing price | $3.96 |
| H/L, today | $3.75 / $4.10 |
| H/L, 52-week | $4.26 / $23.39 |
| Volume, today | 144,599 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.